P918: HIGH RESPONSES RATES WITH SINGLE AGENT BELANTAMAB MAFODOTIN IN RELAPSED SYSTEMIC AL AMYLOIDOSIS

por Khwaja, J., Bomsztyk, J., Mahmood, S., Wisniowski, B., Shah, R., Tailor, A., Yong, K., Popat, R., Rabin, N., Kyriakou, C., Sive, J., Worthington, S., Hart, A., Dowling, E., Correia, N., Bygrave, C., Rydzewski, A., Jamroziak, K., Wechalekar, A.
Publicado 2022

P1221: DIFFUSE LARGE B-CELL LYMPHOMA RICHTER SYNDROME IN CHRONIC LYMPHOCYTIC LEUKEMIA – A RETROSPECTIVE ANALYSIS OF TREATMENT OUTCOMES IN POLISH ADULT LEUKEMIA STUDY GROUP

por Sośnia, O., Danecki, M., Wąsik-Szczepanek, E., Tryc-Szponder, J., Iskierka-Jażdżewska, E., Majeranowski, A., Pruszczyk, K., Krzemień, H., Bołkun, L., Paszkiewicz-Kozik, E., Drozd-Sokołowska, J., Kwiatkowski, J., Wiśniewska-Organek, D., Budziszewska, B., Jamroziak, K., Hus, I., Lech-Marańda, E., Puła, B.
Publicado 2022

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk

por Sava, G P, Speedy, H E, Di Bernardo, M C, Dyer, M J S, Holroyd, A, Sunter, N J, Marr, H, Mansouri, L, Deaglio, S, Karabon, L, Frydecka, I, Jamroziak, K, Woszczyk, D, Juliusson, G, Smedby, K E, Jayne, S, Majid, A, Wang, Y, Dearden, C, Hall, A G, Mainou-Fowler, T, Jackson, G H, Summerfield, G, Harris, R J, Pettitt, A R, Allsup, D J, Bailey, J R, Pratt, G, Pepper, C, Fegan, C, Rosenquist, R, Catovsky, D, Allan, J M, Houlston, R S
Publicado 2015